Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activations

Canadian Cancer Trials Group IND.196 -- Phase I/II Study of GSK1363089 in Patients with Previously Treated Non-Small Cell Lung Cancer Receiving Standard Erlotinib Therapy -- was activated 17 December 2009.

http://www.ctg.queensu.ca/trials/ind/i196/196.html


Canadian Cancer Trials Group IND.199 -- Phase II Study of Temsirolimus (CCI-779) in Patients with Recurrent, Unresectable, Locally Advanced or Metastatic Carcinoma of the Cervix -- was activated 17 December 2009.

http://www.ctg.queensu.ca/trials/ind/i199/199.html